☆ 4.7 Article

Expanding Bioactive Fragment Space with the Generated Database GDB-13s

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Related references

Note: Only part of the references are listed.

Article Chemistry, Medicinal

Molecular Framework Analysis of the Generated Database GDB-13s

Ye Buehler et al.

Summary: The generated databases (GDBs) list billions of possible molecules through systematic enumeration following simple rules of chemical stability and synthetic feasibility. The originality of GDB molecules can be assessed by comparing their Bemis and Murcko molecular frameworks (MFs) with those in public databases. This comparison revealed that GDB-13s MFs had diverse ring sizes and ring systems without linker bonds, making them attractive targets for synthetic chemistry aiming at innovative molecules.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Add to Collection

Editorial Material Chemistry, Multidisciplinary

Rules were made to be broken

Ingo V. Hartung et al.

Summary: The 'rule of 5' has been a highly influential sentence in small-molecule drug discovery for the past twenty five years, shaping the work of medicinal chemists. However, its relevance in today's medicinal chemistry efforts is being questioned.

NATURE REVIEWS CHEMISTRY (2023)

Add to Collection

Review Chemistry, Multidisciplinary

Combining Chemical Protein Synthesis and Random Nonstandard Peptides Integrated Discovery for Modulating Biological Processes

Abhishek Saha et al.

Summary: Chemical manipulation of naturally occurring peptides offers a convenient route for generating analogs to screen different therapeutic targets. mRNA display provides advantages in terms of library size and the recovery of selected polypeptide sequences.

ACCOUNTS OF CHEMICAL RESEARCH (2023)

Add to Collection

Review Multidisciplinary Sciences

Computational approaches streamlining drug discovery

Anastasiia V. Sadybekov et al.

Summary: Computer-aided drug discovery has experienced a significant shift towards computational technologies for efficient ligand screening. This shift is driven by the availability of vast ligand data, abundant computing capacities, and virtual libraries of drug-like small molecules. Recent advances in deep learning predictions of ligand properties and target activities, as well as structure-based virtual screening, have the potential to reshape the drug discovery and development process. The rapid identification of diverse, potent, target-selective, and drug-like ligands to protein targets can democratize the drug discovery process, enabling cost-effective development of safer and more effective treatments.

NATURE (2023)

Add to Collection

Review Biotechnology & Applied Microbiology

Small-molecule discovery through DNA-encoded libraries

Alexander A. Peterson et al.

Summary: DNA-encoded library (DEL) technology is a powerful small-molecule discovery platform, offering many advantages over traditional screening methods. This Review provides accounts of recently described small molecules discovered from DELs, illustrating the versatility, efficiency and broad impact of this technology.

NATURE REVIEWS DRUG DISCOVERY (2023)

Add to Collection

Review Chemistry, Medicinal

Exploration of Ultralarge Compound Collections for Drug Discovery

Wendy A. Warr et al.

Summary: Designing new medicines more cheaply and quickly is closely related to exploring chemical space more widely and efficiently. This review focuses on the collection of millions or even billions of enumerated chemical structures, as well as larger chemical spaces that are not fully enumerated. New technologies for searching large libraries and combinatorially in chemical space are discussed, along with space navigation techniques and the impact of autonomous laboratories on synthesis of designed compounds. Challenges and opportunities for the future are summarized.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)

Add to Collection

Article Business, Finance

Missing Novelty in Drug Development

Joshua Krieger et al.

Summary: Pharmaceutical firms tend to underinvest in radical innovation due to risk aversion, as novel drug candidates are less likely to obtain FDA approval but are based on more valuable patents. A positive shock to firms' net worth leads to the development of more novel drugs, suggesting that even large firms may exhibit risk-averse behavior.

REVIEW OF FINANCIAL STUDIES (2022)

Add to Collection

Article Chemistry, Multidisciplinary

A Potent and Selective Janus Kinase Inhibitor with a Chiral 3D-Shaped Triquinazine Ring System from Chemical Space

Kris Meier et al.

Summary: The study discovered that many chiral, 3D-shaped ring systems, often containing quaternary centers, in the generated databases have not been explored for drug design. By using triquinazine as an example, a nanomolar and selective inhibitor of Janus Kinase 1 was designed, which is related to the marketed drug Tofacitinib used for treating autoimmune diseases.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Add to Collection

Article Chemistry, Multidisciplinary

COCONUT online: Collection of Open Natural Products database

Maria Sorokina et al.

Summary: Natural products (NPs) are bioactive small molecules produced by living organisms, sparking global interest in NP research. Despite the existence of multiple NP databases, there is currently no resource that aggregates all known NPs in one place, which would greatly simplify research.

JOURNAL OF CHEMINFORMATICS (2021)

Add to Collection

Article Chemistry, Medicinal

US FDA Approved Drugs from 2015-June 2020: A Perspective

Priyadeep Bhutani et al.

Summary: This study compiled and analyzed 245 drugs approved by the U.S. FDA from 2015 to June 2020, focusing on cancer, infectious diseases, neurological conditions, and genetic, metabolic, cardiovascular disorders. The analysis also looked at the structural, elemental, and functional group diversity among the approved drugs, as well as drug-likeness for the approved drugs.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Review Chemistry, Medicinal

DNA-Encoded Chemical Libraries: A Comprehensive Review with Succesful Stories and Future Challenges

Adrian Gironda-Martinez et al.

Summary: DNA-encoded chemical libraries (DELs) are a versatile and powerful technology platform for discovering small-molecule ligands to protein targets. Advances in DNA-compatible reactions, selection methodologies, sequencing, and data analysis have enabled the construction and screening of libraries of unprecedented size, leading to the discovery of highly potent ligands. The Review provides an overview of diverse approaches for DEL generation and screening, highlighting recent success stories and future challenges in improving DEL technology for therapeutic discovery.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Visualization of very large high-dimensional data sets as minimum spanning trees

Daniel Probst et al.

JOURNAL OF CHEMINFORMATICS (2020)

Add to Collection

Article Chemistry, Multidisciplinary

The Generated Databases (GDBs) as a Source of 3D-shaped Building Blocks for Use in Medicinal Chemistry and Drug Discovery

Kris Meier et al.

CHIMIA (2020)

Add to Collection

Article Chemistry, Medicinal

rdScaffoldNetwork: The Scaffold Network Implementation in RDKit

Franziska Kruger et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Add to Collection

Article Chemistry, Multidisciplinary

One molecular fingerprint to rule them all: drugs, biomolecules, and the metabolome

Alice Capecchi et al.

JOURNAL OF CHEMINFORMATICS (2020)

Add to Collection

Article Multidisciplinary Sciences

Generating Multibillion Chemical Space of Readily Accessible Screening Compounds

Oleksandr O. Grygorenko et al.

ISCIENCE (2020)

Add to Collection

Article Chemistry, Medicinal

ZINC20-A Free Ultralarge-Scale Chemical Database for Ligand Discovery

John J. Irwin et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Add to Collection

Review Pharmacology & Pharmacy

The next level in chemical space navigation: going far beyond enumerable compound libraries

Torsten Hoffmann et al.

DRUG DISCOVERY TODAY (2019)

Add to Collection

Article Chemistry, Medicinal

Are We Opening the Door to a New Era of Medicinal Chemistry or Being Collapsed to a Chemical Singularity?

Yan A. Ivanenkov et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

PubChem 2019 update: improved access to chemical data

Sunghwan Kim et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Article Biochemistry & Molecular Biology

ChEMBL: towards direct deposition of bioassay data

David Mendez et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Review Chemistry, Organic

Chemical composition of DNA-encoded libraries, past present and future

Paige Dickson et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Opportunities and guidelines for discovery of orally absorbed drugs in beyond rule of 5 space

Vasanthanathan Poongavanam et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Exhaustive sampling of the fragment space associated to a molecule leading to the generation of conserved fragments

Kathrin Heikamp et al.

CHEMICAL BIOLOGY & DRUG DESIGN (2018)

Add to Collection

Article Chemistry, Medicinal

Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag

Tairan Liu et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)

Add to Collection

Editorial Material Multidisciplinary Sciences

THE DRUG-MAKER'S GUIDE TO THE GALAXY

Asher Mullard

NATURE (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Cyclic peptide therapeutics: past, present and future

Alessandro Zorzi et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2017)

Add to Collection

Article Biochemical Research Methods

molBLOCKS: decomposing small molecule sets and uncovering enriched fragments

Dario Ghersi et al.

BIOINFORMATICS (2014)

Add to Collection

Article Chemistry, Medicinal

Rings in Drugs

Richard D. Taylor et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Add to Collection

Review Chemistry, Multidisciplinary

The enumeration of chemical space

Jean-Louis Reymond et al.

WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2012)

Add to Collection

Article Chemistry, Multidisciplinary

970 Million Druglike Small Molecules for Virtual Screening in the Chemical Universe Database GDB-13

Lorenz C. Blum et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)

Add to Collection

Article Chemistry, Multidisciplinary

Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions

Peter Ertl et al.

JOURNAL OF CHEMINFORMATICS (2009)

Add to Collection

Article Chemistry, Medicinal

On the Art of Compiling and Using 'Drug-Like' Chemical Fragment Spaces

Joerg Degen et al.

CHEMMEDCHEM (2008)

Add to Collection

Article Chemistry, Medicinal

Natural product-likeness score and its application for prioritization of compound libraries

Peter Ertl et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)

Add to Collection

Review Biotechnology & Applied Microbiology

A decade of fragment-based drug design: strategic advances and lessons learned

Philip J. Hajduk et al.

NATURE REVIEWS DRUG DISCOVERY (2007)

Add to Collection

Review Chemistry, Medicinal

Fragment-based drug discovery

DA Erlanson et al.

JOURNAL OF MEDICINAL CHEMISTRY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.